Literature DB >> 17229797

Expression of hypoxia-inducible factor-1alpha and the protein products of its target genes in diabetic fibrovascular epiretinal membranes.

Ahmed M Abu El-Asrar1, Luc Missotten, Karel Geboes.   

Abstract

AIMS: To investigate the expression of the hypoxia-inducible factor-1alpha (HIF-1alpha) and the protein products of its target genes vascular endothelial growth factor (VEGF), erythropoietin (Epo) and angiopoietins (Angs), and the antiangiogenic pigment epithelium-derived factor (PEDF) in proliferative diabetic retinopathy (PDR) epiretinal membranes.
METHODS: Sixteen membranes were studied by immunohistochemical techniques.
RESULTS: Vascular endothelial cells expressed HIF-1alpha, Ang-2 and VEGF in 15 (93.75%), 6 (37.5%) and 9 (56.25%) membranes, respectively. There was no immunoreactivity for Epo, Ang-1 and PEDF. There were significant correlations between the number of blood vessels expressing the panendothelial marker CD34 and the numbers of blood vessels expressing HIF-1alpha (r = 0.554; p = 0.026), Ang-2 (r = 0.830; p<0.001) and VEGF (r = 0.743; p = 0.001). The numbers of blood vessels expressing Ang-2 and VEGF in active membranes were higher than that in inactive membranes (p = 0.015 and 0.028, respectively).
CONCLUSIONS: HIF-1alpha, Ang-2 and VEGF may play an important role in the pathogenesis of PDR. The findings suggest an adverse angiogenic milieu in PDR epiretinal membranes favouring aberrant neovascularisation and endothelial abnormalities.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17229797      PMCID: PMC1955571          DOI: 10.1136/bjo.2006.109876

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  45 in total

Review 1.  Vascular-specific growth factors and blood vessel formation.

Authors:  G D Yancopoulos; S Davis; N W Gale; J S Rudge; S J Wiegand; J Holash
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

2.  Angiopoietins can directly activate endothelial cells and neutrophils to promote proinflammatory responses.

Authors:  Caroline Lemieux; Ricardo Maliba; Judith Favier; Jean-François Théorêt; Yahye Merhi; Martin G Sirois
Journal:  Blood       Date:  2004-10-21       Impact factor: 22.113

3.  Hypoxia-inducible angiopoietin-2 expression is mimicked by iodonium compounds and occurs in the rat brain and skin in response to systemic hypoxia and tissue ischemia.

Authors:  S J Mandriota; C Pyke; C Di Sanza; P Quinodoz; B Pittet; M S Pepper
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

4.  Pigment epithelium-derived factor: a potent inhibitor of angiogenesis.

Authors:  D W Dawson; O V Volpert; P Gillis; S E Crawford; H Xu; W Benedict; N P Bouck
Journal:  Science       Date:  1999-07-09       Impact factor: 47.728

5.  Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization.

Authors:  G Gao; Y Li; D Zhang; S Gee; C Crosson; J Ma
Journal:  FEBS Lett       Date:  2001-02-02       Impact factor: 4.124

6.  Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.

Authors:  Daisuke Watanabe; Kiyoshi Suzuma; Izumi Suzuma; Hirokazu Ohashi; Tomonari Ojima; Masafumi Kurimoto; Tomoaki Murakami; Tetsushi Kimura; Hitoshi Takagi
Journal:  Am J Ophthalmol       Date:  2005-03       Impact factor: 5.258

7.  Transient expression of hypoxia-inducible factor-1 alpha and target genes in peripheral nerves from diabetic rats.

Authors:  Juan C Chavez; Khaldoun Almhanna; Liliana N Berti-Mattera
Journal:  Neurosci Lett       Date:  2004-11-23       Impact factor: 3.046

8.  Angiopoietin 1 prevents retinal detachment in an aggressive model of proliferative retinopathy, but has no effect on established neovascularization.

Authors:  Hiroyuki Nambu; Naoyasu Umeda; Shu Kachi; Yuji Oshima; Hideo Akiyama; Rie Nambu; Peter A Campochiaro
Journal:  J Cell Physiol       Date:  2005-07       Impact factor: 6.384

9.  Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway.

Authors:  L E Huang; J Gu; M Schau; H F Bunn
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

10.  Temporal, spatial, and oxygen-regulated expression of hypoxia-inducible factor-1 in the lung.

Authors:  A Y Yu; M G Frid; L A Shimoda; C M Wiener; K Stenmark; G L Semenza
Journal:  Am J Physiol       Date:  1998-10
View more
  22 in total

1.  Phosphorylation of alphaB-crystallin in epiretinal membrane of human proliferative diabetic retinopathy.

Authors:  Yoko Dong; Zhenyu Dong; Satoru Kase; Ryo Ando; Junichi Fukuhara; Satoshi Kinoshita; Saori Inafuku; Yoshiaki Tagawa; Erdal Tan Ishizuka; Wataru Saito; Miyuki Murata; Atsuhiro Kanda; Kousuke Noda; Susumu Ishida
Journal:  Int J Ophthalmol       Date:  2016-08-18       Impact factor: 1.779

2.  A comparison of hypoxia-inducible factor-α in surgically excised neovascular membranes of patients with diabetes compared with idiopathic epiretinal membranes in nondiabetic patients.

Authors:  Jennifer I Lim; Christine Spee; David R Hinton
Journal:  Retina       Date:  2010-10       Impact factor: 4.256

3.  Role of matrix metalloproteinase-2 and -9 in the development of diabetic retinopathy.

Authors:  Ghulam Mohammad; Mohammad Mairaj Siddiquei
Journal:  J Ocul Biol Dis Infor       Date:  2012-07-06

4.  Angiogenic Factors and Cytokines in Diabetic Retinopathy.

Authors:  Steven F Abcouwer
Journal:  J Clin Cell Immunol       Date:  2013

Review 5.  A review of anti-VEGF agents for proliferative diabetic retinopathy.

Authors:  P Osaadon; X J Fagan; T Lifshitz; J Levy
Journal:  Eye (Lond)       Date:  2014-02-14       Impact factor: 3.775

6.  Expression of stem cell factor/c-kit signaling pathway components in diabetic fibrovascular epiretinal membranes.

Authors:  Ahmed M Abu El-Asrar; Sofie Struyf; Ghislain Opdenakker; Jo Van Damme; Karel Geboes
Journal:  Mol Vis       Date:  2010-06-15       Impact factor: 2.367

Review 7.  Hypoxia-inducible factor-1 (HIF-1): a potential target for intervention in ocular neovascular diseases.

Authors:  Ramya Krishna Vadlapatla; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  Curr Drug Targets       Date:  2013-07       Impact factor: 3.465

8.  Downregulation of lentivirus-mediated ILK RNAi on tractional force generation in human retinal Müller cells.

Authors:  Yu-ping Zheng; Hui Liu; Hao Zeng; Lei Xiong; Zhao-hui Feng; Nai-xue Sun
Journal:  Acta Pharmacol Sin       Date:  2009-11-16       Impact factor: 6.150

9.  Expression of erythropoietin receptor in human epiretinal membrane of proliferative diabetic retinopathy.

Authors:  Satoru Kase; Wataru Saito; Kazuhiro Ohgami; Kazuhiko Yoshida; Naoki Furudate; Akari Saito; Masahiko Yokoi; Manabu Kase; Shigeaki Ohno
Journal:  Br J Ophthalmol       Date:  2007-05-23       Impact factor: 4.638

10.  Angiogenic and vasculogenic factors in the vitreous from patients with proliferative diabetic retinopathy.

Authors:  Ahmed M Abu El-Asrar; Mohd Imtiaz Nawaz; Dustan Kangave; Mohammed Mairaj Siddiquei; Karel Geboes
Journal:  J Diabetes Res       Date:  2013-03-10       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.